国际麻醉学与复苏杂志   2019, Issue (9): 0-0
    
右美托咪定肾保护作用的研究进展
翟明玉, 李娟1()
1.中国科学技术大学附属第一医院南区
Research progress of the renoprotection effects of dexmedetomidine
 全文:
摘要:

右美托咪定(dexmedetomidine, Dex)是一种高效、高选择的α2受体激动剂,由于其具有镇静、镇痛、抗焦虑和利尿等作用,同时无明显的呼吸抑制及脑电干扰等副作用,目前作为麻醉辅助用药广泛应用于临床。肾缺血/再灌注损伤是一种发病率及病死率极高、使医疗费明显增加的全球公共卫生问题,实施合理的肾保护策略具有重要意义,麻醉药物的选择和合理使用是围手术期实施肾保护策略的一个重要方面。近年大量研究均发现Dex具有肾保护作用。文章综述Dex对肾缺血/再灌注损伤的保护作用及机制的研究进展,使人们更深入理解Dex的肾保护作用及可能机制,从而合理应用Dex改善相关患者的预后。

关键词: 右美托咪定; 肾; 再灌注损伤; 保护作用
Abstract:

Dexmedetomidine(Dex) served as a highly selective α2 adrenoceptor agonist, which exhibits sedation, analgesia, anti-anxiety, diuresis effects and so on. Meanwhile, it has low side-effects including respiratory depression and brain electrical interference. As it′s widely used as analgesic and sedative depressant tranquilizer application in clinic. Kidney ischemia/reperfusion injury is a global public health concern associated with high morbidity, mortality, and healthcare costs. It is of great significance to implement reasonable renal protection strategies, and optimization of perioperative medications may be an important strategy in renal protection. Recent studies show that Dex has renoprotection. This paper reviews the renoprotection of Dex and the possible mechanisms, which may able to make people further understood the renal protective effect and possible mechanisms of Dex, so as to reasonable application Dex to improve the prognosis of related patients.

Key words: Dexmedetomidine; Kidney; Reperfusion injury; Protection